title: No end in sight for telomerase-targeted cancer drugs.
authors.forename: Sarah C P
authors.initials: SC
authors.lastname: Williams
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D007211:Indoles / Q000494:pharmacology / Q000627:therapeutic use; D058990:Molecular Targeted Therapy; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D009536:Niacinamide / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D009841:Oligonucleotides; D010446:Peptide Fragments / Q000494:pharmacology / Q000627:therapeutic use; D019098:Telomerase / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D013922:Thrombocytosis / Q000188:drug therapy
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D009841:Oligonucleotides; D010446:Peptide Fragments; D009536:Niacinamide; C514987:GV1001 peptide; D019098:Telomerase; C519562:imetelstat